Filing Details
- Accession Number:
- 0001859061-23-000007
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-06-02 17:00:32
- Reporting Period:
- 2023-05-31
- Accepted Time:
- 2023-06-02 17:00:32
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1840439 | Biomea Fusion Inc. | BMEA | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1859061 | A2A Pharmaceuticals, Inc. | 59 5Th Ave New York NY 10003 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2023-05-31 | 75,000 | $33.81 | 3,550,000 | No | 4 | S | Direct | |
Common Stock | Disposition | 2023-06-01 | 50,000 | $34.56 | 3,500,000 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- A total of 75,000 shares were sold at an average price of 33.81 in multiple transactions ranging from 33.44 to 34.43. Details of the specific transactions are available upon request.
- A total of 50,000 shares were sold at an average price of 34.5633 in multiple transactions ranging from 34.50 to 35.02 Details of the specific transactions are available upon request.